Ameriprise Financial Inc. lessened its stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 11.5% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 62,792 shares of the medical instruments supplier's stock after selling 8,143 shares during the period. Ameriprise Financial Inc. owned 0.30% of Mettler-Toledo International worth $74,152,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT acquired a new position in Mettler-Toledo International in the 1st quarter valued at about $43,000. Golden State Wealth Management LLC increased its position in Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after purchasing an additional 35 shares during the period. Menard Financial Group LLC acquired a new position in Mettler-Toledo International during the 4th quarter worth approximately $67,000. Blue Trust Inc. increased its position in Mettler-Toledo International by 520.0% during the 1st quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock worth $73,000 after purchasing an additional 52 shares during the period. Finally, Farther Finance Advisors LLC increased its position in Mettler-Toledo International by 39.1% during the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after purchasing an additional 25 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.
Analyst Ratings Changes
Several equities analysts have issued reports on MTD shares. Robert W. Baird boosted their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their target price for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their target price for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Barclays started coverage on Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target on the stock. Finally, Evercore ISI lowered their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $1,311.11.
View Our Latest Analysis on Mettler-Toledo International
Mettler-Toledo International Price Performance
NYSE:MTD traded up $19.63 during trading hours on Friday, reaching $1,302.74. 100,599 shares of the company traded hands, compared to its average volume of 151,491. The firm's 50-day moving average is $1,240.96 and its 200-day moving average is $1,185.95. The stock has a market cap of $26.84 billion, a P/E ratio of 32.99, a P/E/G ratio of 3.90 and a beta of 1.34. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,521.01.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.
Insider Activity
In other news, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the sale, the insider owned 94 shares of the company's stock, valued at $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares of the company's stock, valued at approximately $6,750,875. This represents a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,827 shares of company stock valued at $2,371,208 over the last quarter. Company insiders own 1.94% of the company's stock.
About Mettler-Toledo International
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Recommended Stories

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report